Crossmark

A multifaceted cellular damage repair and prevention pathway promotes high‐level tolerance to β‐lactam antibiotics

Crossref DOI link: https://doi.org/10.15252/embr.202051790

Published Online: 2021-01-18

Published Print: 2021-02-03

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Shin, Jung‐Ho https://orcid.org/0000-0001-9411-1331
Choe, Donghui https://orcid.org/0000-0003-1107-7380
Ransegnola, Brett

Hong, Hye‐Rim https://orcid.org/0000-0002-8339-3190
Onyekwere, Ikenna

Cross, Trevor

Shi, Qiaojuan https://orcid.org/0000-0002-7588-2445
Cho, Byung‐Kwan https://orcid.org/0000-0003-4788-4184
Westblade, Lars F

Brito, Ilana L

Dörr, Tobias https://orcid.org/0000-0003-3283-9161
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2018M3A9H3024759)

National Institutes of Health (R01AI143704)

National Institutes of Health (R01GM130971)

National Institutes of Health (1DP2HL141007)
License Information

Version of Record valid from 2021-01-18
More Information

Publication History

Received: 2020-09-25

Accepted: 2020-12-02

Published: 2021-01-18